Evrysdi is approved in 70 countries and submitted in a further 31 with more than 4,500 patients treated to date
APS03118 is a novel innovative drug developed by APS with global independent intellectual property rights for unlimited cancer types
UCB plans to submit regulatory applications in Q3 2022
Pfizer is evaluating the FDA’s comments and will work with the agency to determine an appropriate path forward
However, these won’t be available at the nearest chemist store soon
New data from ongoing trial showed increased antibody response against Beta, Delta, Alpha, Gamma and Omicron variants following third dose booster with Vaxzevria
KardiaMobile is the first personal ECG to be recommended by NICE for use within the National Health Service (NHS) in England and Wales
First Positive Study for KEYTRUDA in Adjuvant Stage IB-IIIA NSCLC
Novavax' vaccine has received authorizations of the vaccine in over 170 countries
ASC10 is an oral direct-acting antiviral drug candidate targeting RNA dependent RNA polymerase (RdRp) to treat SARS-CoV-2 infection
Subscribe To Our Newsletter & Stay Updated
